Efficacy and tolerability of rufinamide in the treatment of Lennox–Gastaut syndrome (experience of the Svt. Luka’s Association of Medical Institutions)
Background. Lennox–Gastaut syndrome (LGS) is a classic developmental and epileptic encephalopathy with a debut in childhood, characterized by resistance to therapy, a severe course, and an unfavorable prognosis. Due to the existing difficulties in treatment of LGS, hopes are pinned on development of...
Saved in:
| Main Authors: | K. Yu. Mukhin, O. A. Pylaeva, M. Yu. Bobylova, L. Yu. Glukhova, N. V. Freydkova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-01-01
|
| Series: | Русский журнал детской неврологии |
| Subjects: | |
| Online Access: | https://rjdn.abvpress.ru/jour/article/view/448 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy and tolerability of rufinamide in the treatment of epilepsy (experience of the Svt. Luka’s Institute of Child Neurology and Epilepsy)
by: K. Yu. Mukhin, et al.
Published: (2018-11-01) -
RUFINAMIDE IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME: REVIEW OF FOREIGN LITERATURE
by: K. Yu. Mukhin, et al.
Published: (2015-06-01) -
RUFINAMIDE (INOVELON) IN THE TREATMENT OF LENNOX–GASTAUT SYNDROME (A REVIEW OF LITERATURE AND CLINICAL CASE)
by: K. Yu. Mukhin, et al.
Published: (2016-01-01) -
Rufinamide (inovelon) in the treatment of Lennox–gastaut syndrome (a review of literature)
by: К. Yu. Мukhin, et al.
Published: (2018-11-01) -
PHARMACOECONOMIC EVALUATION OF RUFINAMIDE USE FOR THE LENNOX-GASTAUT SYNDROME TREATMENT
by: N. K. Mazina, et al.
Published: (2016-04-01)